Allena Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $31,986,000.
Profit Margin
| 2015 | 0 | -14.24M | |
|---|---|---|---|
| 2016 | 0 | -24.50M | |
| 2017 | 0 | -21.65M | |
| 2018 | 0 | -35.64M | |
| 2019 | 0 | -47.33M | |
| 2020 | 0 | -32.84M | |
| 2021 | 0 | -33.35M |
ALNA Income Statement (2015 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 20.38M | 20.38M | 37.24M | 26.37M | 15.51M | 20.10M | 11.54M |
Selling and marketing | 0 | 0 | 0 | 576K | 0 | 0 | 0 |
Total operating expenses | 31.98M | 31.98M | 46.92M | 35.59M | 20.95M | 24.18M | 13.90M |
Operating income | -32.33M | -31.98M | -46.92M | -35.59M | -20.95M | -24.18M | -13.90M |
Other income (expenses), net | -510K | -859K | -419K | -55K | -700K | -321K | -342K |
Income before tax | -32.84M | -32.84M | -47.33M | -35.64M | -21.65M | -24.50M | -14.24M |
Income tax expense | 510K | -859K | -419K | -55K | -700K | -321K | -342K |
Net income | -33.35M | -32.84M | -47.33M | -35.64M | -21.65M | -24.50M | -14.24M |
Earnings per share | |||||||
Basic EPS | -1.03 | -1.01 | -2.13 | -1.72 | -4.79 | -1.6 | -0.93 |
Diluted EPS | -1.03 | -1.01 | -2.13 | -1.72 | -4.79 | -1.6 | -0.93 |
| Data source | Data source | Data source | Data source | Data source |